L, R., C, R., A, E., ES, B., & HY, M. (2022). Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia. Behavioural brain research, 422, 113710. https://doi.org/10.1016/j.bbr.2021.113710
Chicago Style (17th ed.) CitationL, Rajagopal, Ryan C, Elzokaky A, Burstein ES, and Meltzer HY. "Pimavanserin Augments the Efficacy of Atypical Antipsychotic Drugs in a Mouse Model of Treatment-refractory Negative Symptoms of Schizophrenia." Behavioural Brain Research 422 (2022): 113710. https://doi.org/10.1016/j.bbr.2021.113710.
MLA (9th ed.) CitationL, Rajagopal, et al. "Pimavanserin Augments the Efficacy of Atypical Antipsychotic Drugs in a Mouse Model of Treatment-refractory Negative Symptoms of Schizophrenia." Behavioural Brain Research, vol. 422, 2022, p. 113710, https://doi.org/10.1016/j.bbr.2021.113710.